223 related articles for article (PubMed ID: 31554387)
1. Evaluation of Patched-1 Protein Expression Level in Low Risk and High Risk Basal Cell Carcinoma Subtypes.
Almomani R; Khanfar M; Bodoor K; Al-Qarqaz F; Alqudah M; Hammouri H; Abu-Salah A; Haddad Y; Al Gargaz W; Mohaidat Z
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2851-2857. PubMed ID: 31554387
[TBL] [Abstract][Full Text] [Related]
2. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice.
Mancuso M; Pazzaglia S; Tanori M; Hahn H; Merola P; Rebessi S; Atkinson MJ; Di Majo V; Covelli V; Saran A
Cancer Res; 2004 Feb; 64(3):934-41. PubMed ID: 14871823
[TBL] [Abstract][Full Text] [Related]
3. Patched-2 functions to limit Patched-1 deficient skin cancer growth.
Veenstra VL; Dingjan I; Waasdorp C; Damhofer H; van der Wal AC; van Laarhoven HW; Medema JP; Bijlsma MF
Cell Oncol (Dordr); 2018 Aug; 41(4):427-437. PubMed ID: 29869097
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of phosphorylated MEK and ERK correlates with aggressive BCC subtypes.
Rahman MM; Herath D; Bladen JC; Atkar R; Pirzado MS; Harwood C; Philpott MP; Neill GW
Carcinogenesis; 2021 Jul; 42(7):975-983. PubMed ID: 34003214
[TBL] [Abstract][Full Text] [Related]
5. Alternative activation of hedgehog pathway induced by ultraviolet B radiation: preliminary study.
Lesiak A; Sobolewska-Sztychny D; Bednarski IA; Wódz K; Sobjanek M; Woźniacka A; Narbutt J
Clin Exp Dermatol; 2018 Jul; 43(5):518-524. PubMed ID: 29424103
[TBL] [Abstract][Full Text] [Related]
6. Nevoid Basal Cell Carcinoma Syndrome:
Martinez MF; Romano MV; Martinez AP; González A; Muchnik C; Stengel FM; Mazzuoccolo LD; Azurmendi PJ
Cells; 2019 Feb; 8(2):. PubMed ID: 30754660
[TBL] [Abstract][Full Text] [Related]
7. PTCH1 gene haplotype association with basal cell carcinoma after transplantation.
Begnini A; Tessari G; Turco A; Malerba G; Naldi L; Gotti E; Boschiero L; Forni A; Rugiu C; Piaserico S; Fortina AB; Brunello A; Cascone C; Girolomoni G; Gomez Lira M
Br J Dermatol; 2010 Aug; 163(2):364-70. PubMed ID: 20346027
[TBL] [Abstract][Full Text] [Related]
8. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog Pathway Alterations Downstream of Patched-1 Are Common in Infundibulocystic Basal Cell Carcinoma.
Russell-Goldman E; MacConaill L; Hanna J
Am J Dermatopathol; 2021 Apr; 43(4):266-272. PubMed ID: 32796174
[TBL] [Abstract][Full Text] [Related]
10. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
Bartoš V; Kullová M
Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
[TBL] [Abstract][Full Text] [Related]
11. Actin expression in purely nodular versus nodular-infiltrative basal cell carcinoma.
Law AM; Oliveri CV; Pacheco-Quinto X; Horenstein MG
J Cutan Pathol; 2003 Apr; 30(4):232-6. PubMed ID: 12680952
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma.
Kim HS; Kim YS; Lee C; Shin MS; Kim JW; Jang BG
PLoS One; 2019; 14(11):e0225511. PubMed ID: 31756206
[TBL] [Abstract][Full Text] [Related]
13. A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.
Rahman MM; Hazan A; Selway JL; Herath DS; Harwood CA; Pirzado MS; Atkar R; Kelsell DP; Linton KJ; Philpott MP; Neill GW
Cancer Res; 2018 May; 78(10):2577-2588. PubMed ID: 29463581
[TBL] [Abstract][Full Text] [Related]
14. Neuronal differentiation in basal cell carcinoma: possible relationship to Hedgehog pathway activation?
Gore SM; Kasper M; Williams T; Regl G; Aberger F; Cerio R; Neill GW; Philpott MP
J Pathol; 2009 Sep; 219(1):61-8. PubMed ID: 19479712
[TBL] [Abstract][Full Text] [Related]
15. Comparison of PTCH1, COX-2, p53, and Ki-67 protein expression in basal cell carcinomas of nodular and superficial subtypes arising on the head and trunk.
Khalesi M; Waterhouse M; Whiteman DC; Johns R; Rosendahl C; Hackett T; Pollak T; Kimlin MG; Hacker E; Neale RE;
Int J Dermatol; 2016 Oct; 55(10):1096-105. PubMed ID: 27126210
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis.
Kaur P; Mulvaney M; Carlson JA
Am J Dermatopathol; 2006 Aug; 28(4):293-307. PubMed ID: 16871032
[TBL] [Abstract][Full Text] [Related]
17. Patched1 inhibits epidermal progenitor cell expansion and basal cell carcinoma formation by limiting Igfbp2 activity.
Villani RM; Adolphe C; Palmer J; Waters MJ; Wainwright BJ
Cancer Prev Res (Phila); 2010 Oct; 3(10):1222-34. PubMed ID: 20858761
[TBL] [Abstract][Full Text] [Related]
18. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma.
Yalcin O; Sezer E; Kabukcuoglu F; Kilic AI; Sari AG; Cerman AA; Altunay IK
Int J Clin Exp Pathol; 2015; 8(11):15448-53. PubMed ID: 26823913
[TBL] [Abstract][Full Text] [Related]
19. PTCH1 gene variants rs357564, rs2236405, rs2297086 and rs41313327, mRNA and tissue expression in basal cell carcinoma patients from Western Mexico.
Zambrano-Román M; Padilla-Gutiérrez JR; Valle Y; Muñoz-Valle JF; Guevara-Gutiérrez E; Martínez-Fernández DE; Valdés-Alvarado E
J Clin Lab Anal; 2024 Feb; 38(3):e25010. PubMed ID: 38287479
[TBL] [Abstract][Full Text] [Related]
20. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]